Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Patrycja Nejman-Gryz (Warsaw, Poland), Patrycja Nejman-Gryz, Katarzyna Górska, Magdalena Paplinska-Goryca, Malgorzata Proboszcz. Periostin and TSLP: New markers useful in diagnosis of obstructive lung disease. Eur Respir J 2015; 46: Suppl. 59, 3613

Member's Comments

No comment yet.

Related content which might interest you: Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Evaluation of fatigue state with virus-related novel biomarkers in obstructive lung diseases Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Phenotypic characterization of asthma-COPD overlap syndrome: Comparison with asthma and COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Patients’ adherence to chronic treatment of pulmonary diseases Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Innovations in differentiation of pulmonary and cardiac dyspnea genesis Source: International Congress 2015 – COPD: interesting notes Year: 2015 Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Use of clinical characteristics to predict spirometric classification of obstructive lung disease Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Improved characterization of obstructive airways diseases by parameterization of specific resistance loops Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Prognostic significance of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Survivin in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Thoracic high resolution computed tomography may be helpful in the differentiation between the patients with chronic obstructive pulmonary disease and the smoking patients with asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 LATE-BREAKING ABSTRACT: Serum periostin as a valuable biomarker of comorbid chronic rhinosinusitis in patients with asthma Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016